These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3855542

  • 1. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.
    Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S.
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):193-7. PubMed ID: 3855542
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
    Zoja C, Perico N, Corna D, Benigni A, Gabanelli M, Morigi M, Bertani T, Remuzzi G.
    J Am Soc Nephrol; 1990 Nov; 1(5):799-807. PubMed ID: 2133429
    [Abstract] [Full Text] [Related]

  • 3. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T, Ikeda T, Ishimitsu T, Uehara Y.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
    Zoja C, Benigni A, Livio M, Bergamelli A, Orisio S, Abbate M, Bertani T, Remuzzi G.
    Am J Pathol; 1989 May; 134(5):1027-38. PubMed ID: 2497648
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C, Papanikolaou N.
    Experientia; 1986 Jun 15; 42(6):613-5. PubMed ID: 3522267
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ, Driscoll EM, Romson JL, Pitt B, Lucchesi BR.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):285-91. PubMed ID: 6542526
    [Abstract] [Full Text] [Related]

  • 14. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA, Andres GA, Dunn MJ.
    J Clin Invest; 1983 Oct 15; 72(4):1439-48. PubMed ID: 6685136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    Nagao T, Ito M, Nagamatsu T, Suzuki Y.
    Eur J Pharmacol; 1994 Jul 11; 259(3):233-42. PubMed ID: 7982449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.